ArticleNucleic acids research2016
The European Bioinformatics Institute in 2016: Data growth and integration.
Article in Nucleic acids research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
48 citing papers in PubMed.
- Development of a genetic priority score to predict drug side effects using human genetic evidence.Nature communications · 2025Article
- A data-intelligence-intensive bioinformatics copilot system for large-scale omics research and scientific insights.Briefings in bioinformatics · 2025Article
- Transcriptome Derived Artificial neural networks predict PRRC2A as a potent biomarker for epilepsy.Journal, genetic engineering & biotechnology · 2025Article
- Unraveling druggable cancer-driving proteins and targeted drugs using artificial intelligence and multi-omics analyses.Scientific reports · 2024Article
- FishSNP: a high quality cross-species SNP database of fishes.Scientific data · 2024Article
- An interconnected data infrastructure to support large-scale rare disease research.GigaScience · 2024Article
- Perspectives on tracking data reuse across biodata resources.Bioinformatics advances · 2024Article
- Development of a human genetics-guided priority score for 19,365 genes and 399 drug indications.Nature genetics · 2024Article
- Papyrus: a large-scale curated dataset aimed at bioactivity predictions.Journal of cheminformatics · 2023Article
- Prostate cancer in omics era.Cancer cell international · 2022Article
- Article
- Murine allele and transgene symbols: ensuring unique, concise, and informative nomenclature.Mammalian genome : official journal of the International Mammalian Genome Society · 2022Review
- ELIXIR-EXCELERATE: establishing Europe's data infrastructure for the life science research of the future.The EMBO journal · 2021Article
- The Biological Significance of Multi-copy Regions and Their Impact on Variant Discovery.Genomics, proteomics & bioinformatics · 2020Article
- Novel phylogenetic methods are needed for understanding gene function in the era of mega-scale genome sequencing.Nucleic acids research · 2020Article
- MiST 3.0: an updated microbial signal transduction database with an emphasis on chemosensory systems.Nucleic acids research · 2020Article
- Article
- An open-source GIS-enabled lookup service for Nagoya Protocol party information.Database : the journal of biological databases and curation · 2020Article
- geneHummus: an R package to define gene families and their expression in legumes and beyond.BMC genomics · 2019Article
- The EMBL-EBI search and sequence analysis tools APIs in 2019.Nucleic acids research · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
New technologies are revolutionising biological research and its applications by making it easier and cheaper to generate ever-greater volumes and types of data. In response, the services and infrastructure of the European Bioinformatics Institute (EMBL-EBI, www.ebi.ac.uk) are continually expanding: total disk capacity increases significantly every year to keep pace with demand (75 petabytes as of December 2015), and interoperability between resources remains a strategic priority. Since 2014 we have launched two new resources: the European Variation Archive for genetic variation data and EMPIAR for two-dimensional electron microscopy data, as well as a Resource Description Framework platform. We also launched the Embassy Cloud service, which allows users to run large analyses in a virtual environment next to EMBL-EBI's vast public data resources.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.